Global Stem Cell Banking Market Trends and Drivers, Restraints, and Opportunities 2017-2023

  • Product Code:
  • Published Date:
    17 Jul 2021
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More


Market Overview:

Stem Cell Banking Market – Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Stem cells are undifferentiated biological cells that can distinguish into specialized cells, tissue, or an organ. The process of storing these stem cells for the treatment of life threatening diseases in the future is called stem cell banking. Nearly 500 stem cell banks are functioning globally, and every bank is now striving harder to increase their market share. Stem cell banking has applications in cerebral palsy, thalassemia, leukemia, diabetes, autism, and others. Cerebral palsy holds the major share of nearly quarter of the market share among the various applications. Private stem cell banks are implementing innumerable publicizing strategies to upsurge their product visibility among people.
The market is driven by factors such as easy method of extraction of stem cells from the samples, increasing birth rate, increased awareness of stem cell therapeutics, and increasing potentials of stem cell treatment. Alongside, the collaboration among the cord blood banks, increasing investments and fundings, and automation of procedures for the banking of stem cells are providing opportunities for the growth of the stem cell banking market. However, intense competition, high operating costs, changes in legal regulations, and high entry barriers are the major factors hampering the market growth.
Market Analysis: The “Stem Cell Banking Market” is estimated to witness a CAGR of 16.4% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product types, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the stem cell banking market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. India, China, and Japan are set to be the most attractive destinations due to the large untapped market.
Product Types Analysis: The stem cell banking market by products is segmented into umbilical cord blood & cord tissue, and adult stem cell banking. The umbilical cord blood & tissue occupies the major share in the market and is also expected to grow at a fast CAGR during the forecast period. The dental stem cell banking and menstrual blood stem cell banking are the latest diversifications in the stem cell banking market. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global stem cell banking market.
Key Players: Esperite, Caladrius Biosciences, Via Cord, CBR Systems, Smart Cells, Life Cell, China Cord Blood, Cryo-Cell, StemCyte, Cordvida, ViaCord, Cryoviva, and other predominate & niche players.
Competitive Analysis: These days, stem cell banks exist in most of the developed and developing nations. Around 450 companies are publicizing cord blood banking services internationally, which signifies intense competition in the market. Globally, China Cord Blood Corporation (CCBC) is expected to be the fastest growing stem cell bank worldwide and in the US, it is Amricord. In 2014, the company Amricord achieved 2,200% growth rate from 2011-2013. Future Health Biobank, American Cryostem, Adicyte, Adisave, Celltex, and Vault Stem currently hold around two-thirds of the Mesenchymal Stem Cells (MSC) storage market. However, at present, these companies are still trivial but are swiftly intensifying. Cryostem witnessed its revenue to nearly double in 2016 from $400,000 to almost $800,000.
Benefits: The report provides complete details about the usage and adoption rate of stem cell banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives toward the stem cell therapy and banking adoption in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook


Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market 8
1.3 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition – Infoholic Research 13
3.2 Segmented Addressable Market (SAM) 13
3.2.1 Evolution of Stem Cell Banking 13
3.2.2 Advantages of Stem Cell 15
3.3 Steps involved in the Stem Cell Banking 16
3.4 Trends of Stem Cell Banking Market 19
3.5 Related Addressable Markets (RAM) 21
3.5.1 Genome Engineering 21
3.5.2 Single Cell Analysis 21
4 Market Outlook 22
4.1 Overview 22
4.2 Market Segmentation 23
4.3 Porter 5(Five) Forces 23
4.4 PEST Analysis 24
5 Market Characteristics 25
5.1 Market Dynamics 26
5.1.1 Drivers 26 Easy Stem Cell Extraction Method from The Sample 26 Increasing global Birth-rate 26 Potentials of stem cell in treatment of various diseases 26
5.1.2 Opportunities 27 Increasing investment in Stem Cell Banking 27 Merger and Acquisition 27
5.1.3 Restraints 28 High operating cost 28 Lack of acceptance 28 Government Regulation 28
5.1.4 DRO – Impact Analysis 29
5.1.5 Key Stakeholders 29
6 Source Types: Market Size and Analysis 31
6.1 Overview 31
6.1.1 Umbilical Cord Blood and Tissue Banking 31
6.1.2 Adult Stem Cell Banking 33
7 Stem Cell Bank Types: Market Size and Analysis 35
7.1 Overview 35
7.1.1 Private Stem Cell Banks 35
7.1.2 Public Stem Cell Banks 36
8 Regions: Market Size and Analysis 37
8.1 Overview 37
8.2 North America 38
8.2.1 Overview 38
8.2.2 US 38
8.2.3 Canada 39
8.3 Europe 39
8.3.1 Overview 39 UK 40 Germany 40 France 41 Italy 41
8.4 APAC 41
8.4.1 Overview 41 India 42 Taiwan 43 China 43
8.5 Rest of the World 44
8.5.1 Overview 44 Brazil 45 South Africa 45 Ecuador 46
9 Competitive Landscape 47
10 Vendor Profiles 50
10.1 Esperite N.V. 50
10.1.1 Overview 50
10.1.2 Business Unit 51
10.1.3 Geographic Presence 52
10.1.4 Business Focus 53
10.1.5 SWOT Analysis 53
10.1.6 Business Strategy 54
10.2 Caladrius Biosciences, Inc. 55
10.2.1 Overview 55
10.2.2 Business Unit 58
10.2.3 Business Focus 59
10.2.4 SWOT Analysis 59
10.2.5 Business Strategy 59
10.3 Cryo-Cell International 60
10.3.1 Overview 60
10.3.2 Highlights 61
10.4 China Cord Blood Corporation. 62
10.4.1 Overview 62
10.4.2 SWOT Analysis 63
10.4.3 Business Strategy 63
10.5 StemCyte India Therapeutics Pvt. Ltd., 63
10.5.1 Overview 63
10.5.2 Highlights 64
10.6 CBR Systems Inc. 64
10.6.1 Overview 64
10.6.2 Highlights 64
10.7 Smart Cell UK 65
10.7.1 Overview 65
10.7.2 Highlights 65
10.8 LifeCell. 65
10.8.1 Overview 65
10.8.2 Highlights 66
10.9 CordVida 67
10.9.1 Overview 67
10.9.2 Highlights 67
10.10 ViaCord 67
10.10.1 Overview 67
10.10.2 Highlights 68
10.11 Cryo-Cell International 68
10.11.1 Overview 68
10.12 Cryoviva Biotech Pvt Ltd 68
10.12.1 Overview 68
10.12.2 Highlights 69
Annexure 69
Abbreviations 69

Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Esperite, Caladrius Biosciences, Via Cord, CBR Systems, Smart Cells, Life Cell, China Cord Blood, Cryo-Cell, StemCyte, Cordvida, ViaCord, Cryoviva, and other predominate & niche players
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports